Vancomycin Dosing for Pneumonia in Critically Ill Trauma Patients
- 1 October 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Trauma: Injury, Infection & Critical Care
- Vol. 67 (4), 802-804
- https://doi.org/10.1097/ta.0b013e31818e90d2
Abstract
Background: Vancomycin has been recommended as the treatment of choice for methicillin-resistant Staphylococcus aureus (MRSA) pneumonia with a desired trough concentration of 15 to 20 mg/L. The purpose of this study was to evaluate the initial dosing of vancomycin for MRSA pneumonia in critically ill adult trauma patients. Methods: Critically ill adult trauma patients were retrospectively identified for inclusion into the study. Patients initiated at a dose of 1 g intravenously (i.v.) every 8 hours were compared with patients initiated at a dose of 1 g i.v. every 12 hours. Baseline continuous demographic variables and steady-state vancomycin trough concentrations were compared between the two groups using a Student's t test (alpha = 0.05). Results: There were 36 patients who satisfied criteria for inclusion 17 patients in the 1 g every 8 hour group and 19 patients in the 1 g every 12 hour group. The mean steady-state trough concentration was higher in the 1 g every 8 hour group versus the 1 g every 12 hour group (11.1 vs. 6.8 mg/L, p = 0.014). A steady-state trough concentration greater than 15 mg/L was achieved in 23.5% of the patients in the 1 g every 8 hour group and none of the patients in the 1 g every 12 hour group. Conclusion: A vancomycin regimen of 1 g i.v. every 12 hours in critically ill trauma patients with MRSA pneumonia and normal renal function is unlikely to achieve trough concentrations of 15 to 20 mg/L. Doses of at least 1 g i.v. every 8 hours are needed.Keywords
This publication has 9 references indexed in Scilit:
- High-Dose Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus InfectionsArchives of Internal Medicine, 2006
- Antibacterial Dosing in Intensive CareClinical Pharmacokinetics, 2006
- Gram-Positive Cocci Infections in Intensive CareDrugs, 2006
- Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract InfectionsClinical Pharmacokinetics, 2004
- National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003American Journal of Infection Control, 2003
- Population Pharmacokinetics of Aminoglycosides in Critically Ill Trauma Patients on Once-Daily RegimensPublished by Wolters Kluwer Health ,2000
- Pulmonary disposition of vancomycin in critically ill patients.European Journal of Clinical Microbiology & Infectious Diseases, 1997
- Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patientsAntimicrobial Agents and Chemotherapy, 1993